Cell and gene therapies harbor great hopes for biomedicine. They are becoming increasingly important for diseases that are currently difficult or impossible to treat—for example, aggressive forms of ...

A single-center, retrospective study demonstrated the major success of immunosuppressive therapies in contributing to complete remission in patients with acquired hemophilia A. Immunosuppressive ...

This rare immune-related adverse event has only been previously reported 4 times in the context of immune checkpoint inhibitor (ICI) treatment. Acquired hemophilia A (AHA) occurs when a patient ...

A research team led by Dr. Albert Sin Chun-fung from the Department of Pathology, School of Clinical Medicine, LKS Faculty of Medicine of the University of Hong Kong (HKUMed) has achieved a ...

When columnist Joe MacDonald woke up Saturday morning with a strained back, his son Caeleb offered his father some lessons in caregiving.

Early emicizumab (Hemlibra) prophylaxis alone prevented clinically relevant bleeds in patients with newly diagnosed acquired hemophilia A, while avoiding the infectious complications of ...

Hemophilia A is a genetic disorder that affects how well your blood clots. With treatment and proactive management, many people with hemophilia A can lead typical, active lives. Hemophilia is a broad ...

Retiree Chip Hailey, who has a severe form of hemophilia B, participated in a groundbreaking gene therapy trial. Hailey experienced a life-threatening delay in treatment after a car accident, ...